1. Matzke GR, Zhanel GG, Guay DR. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet. 1986; 11:257–282.
Article
2. Rodvold KA, Blum RA, Fischer JH, Zokufa , Rotschafer JC, Crossley KB, Rifes LJ. Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother. 1988; 32:848–852.
Article
3. Jin SJ, Yoon JH, Ahn BS, Chung JA, Song YG. Underestimation of the calculated area under the concentration-time curve based on serum creatinine for vancomycin dosing. Infect Chemother. 2014; 46:21–29.
Article
4. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010; 5:1003–1009.
Article
5. Kuan Y, Hossain M, Surman J, El Nahas AM, Haylor J. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Nephrol Dial Transplant. 2005; 20:2394–2401.
Article
6. Ferreira-Filho SR, Cardoso CC, de Castro LA, Oliveira RM, Sá RR. Comparison of measured creatinine clearance and clearances estimated by Cockcroft-Gault and MDRD formulas in patients with a single kidney. Int J Nephrol. 2011; 2011:626178.
Article